home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Disability Rights, Prenatal Diagnosis and Eugenics: A Cross-Cultural View

 
  June, 28 2005 9:07
your information resource in human molecular genetics
 
     
Disability Rights, Prenatal Diagnosis and Eugenics: A Cross-Cultural View

Journal of Genetic Counseling, Volume 14, Number 3, pp. 183-187, June 2005.

Aviad E. Raz (1, 2)

(1) Department of Behavioral Sciences, Ben-Gurion University of the Negev, Be'er-Sheva, Israel, 84105
(2) Ben-Gurion University, Israel

Abstract: This paper considers the disability rights critique of genetic testing in the context of different communities and the issue of nondirectiveness. Despite the wide usage of genetic diagnosis in Israel, no public debate has emerged there concerning disability rights and prenatal testing. The common attitude that emerged from interviews with Israeli representatives of organizations "of'' and "for'' people with genetic diseases and congenital disabilities can be described as a two-fold view of disability: support of genetic testing during pregnancy, and support of the disabled person after birth. This two-fold view is explained as a secular construction situated in legal, economic and cultural contexts. The paper concludes by considering the implications of the "two-fold view'' of disability for the profession of genetic counseling. It is argued that awareness of the existence of conflicting views among clients-such as the view of the 'disability critique' as well as of the "two-fold view of disability''-should strengthen the significance of nondirectiveness.

Also available online.

(C) Journal of Genetic Counseling.

Posted by: Tressie Dalaya


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.